Urine Drug Screens Miss Substances in Some Pediatric Samples
New research suggests standard drug tests may miss low-level exposure in children—potentially sending them back into unsafe home environments—and suggests an alternative.
New research suggests standard drug tests may miss low-level exposure in children—potentially sending them back into unsafe home environments—and suggests an alternative.
Integrating droplet-based microfluidics and mass spectrometry enhances single-cell proteomics, minimizes sample loss, increasing sensitivity.
Finding themselves in a vicious tug-of-war, clinical labs are struggling to keep pace with emerging designer drugs.
Researchers conducted a comprehensive study on multiple myeloma, identifying early detection methods for aggressive tumors.
Revvity announced a distribution agreement with SCIEX aimed at advancing mass spectrometry solutions in newborn screening products.Â
The Tox Explorer Collection consists of a comprehensive library of analytes, allowing for faster identification and targeted screening assays with 1,500 compounds confirmed in a single analysis.